Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability
- 31 May 1996
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 27 (6) , 1422-1428
- https://doi.org/10.1016/0735-1097(95)00621-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Echocardiography during infusion of dobutamine for identification of reversible dyfunction in patients with chronic coronary artery diseaseJournal of the American College of Cardiology, 1994
- Wanted: dead or alive. Assessment of myocardial viability after thrombolysis.Circulation, 1993
- Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization.Circulation, 1993
- Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction.Circulation, 1993
- Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.Circulation, 1993
- Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularizationAmerican Heart Journal, 1991
- Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation.Circulation, 1991
- Myocardial viability. What does it mean and how do we measure it?Circulation, 1991
- Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomographyJournal of the American College of Cardiology, 1990
- The stunned myocardium: prolonged, postischemic ventricular dysfunction.Circulation, 1982